Colorectal Cancer Surgical Treatment, our Experience
- PMID: 32082011
- PMCID: PMC7007624
- DOI: 10.5455/medarh.2019.73.412-414
Colorectal Cancer Surgical Treatment, our Experience
Abstract
Introduction: Colorectal cancer is the third most common cancer in the male and female population. Surgical treatment of colorectal cancer is based on tumor resection and removal of associated lymph glands.
Aim: The aim of the paper is to present data from a five-year retrospective study of the surgical treatment of colorectal cancer at the Clinic for General and Abdominal Surgery at the Clinical Center of the University of Sarajevo.
Methods: This is a retrospective five-year clinical trial (2014-2018) of patients with and surgically treated for colorectal cancer at the Clinic for General and Abdominal Surgery at the Clinical Center of Sarajevo University.
Results: In the 2014-2018 period, n = 11 172 patients were hospitalized at the Clinic, of which n = 732 were surgically treated for colorectal cancer. 69.80% were operated in an elective program. 30.20% were made as emergencies. 51.09% were male patients and 48.36% were female patients. 97.20% were made by open technique. 2.10% operated by minimally invasive procedure. the most common type of colon tumor is Adenocarcinomas are the most common with 79%.
Conclusions: Better prevention and early detection are required to reduce the incidence of patients, which ultimately leads to more effective treatment and longer survival of colon cancer patients. Operative surgical principles must be adapted to modern trends, minimally invasive procedures (laparoscopic surgery, robotic surgery).
Keywords: cancer; colorectal; prevention; surgical treatment.
© 2019 Mirhan Salibasic, Sadat Pusina, Emir Bicakcic, Anes Pasic, Igor Gavric, Edin Kulovic, Ajdin Rovcanin, Semir Beslija.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
The effect of increasing body mass index on laparoscopic surgery for colon and rectal cancer.Colorectal Dis. 2018 Sep;20(9):778-788. doi: 10.1111/codi.14107. Epub 2018 May 4. Colorectal Dis. 2018. PMID: 29577556
-
Laparoscopic vs. open approach for pT3/pT4 colorectal cancer in the elderly: ten-year experience in a single center.Minerva Chir. 2018 Feb;73(1):20-28. doi: 10.23736/S0026-4733.17.07417-X. Epub 2017 Nov 20. Minerva Chir. 2018. PMID: 29154512
-
The short-term outcomes of conventional and single-port laparoscopic surgery for colorectal cancer.Ann Surg. 2011 Dec;254(6):933-40. doi: 10.1097/SLA.0b013e318237826b. Ann Surg. 2011. PMID: 22107740
-
Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Ann Surg. 2018 Jun;267(6):1034-1046. doi: 10.1097/SLA.0000000000002523. Ann Surg. 2018. PMID: 28984644
-
[Laparoscopic surgery for colorectal cancer].Tidsskr Nor Laegeforen. 2007 Nov 15;127(22):2946-9. Tidsskr Nor Laegeforen. 2007. PMID: 18026242 Review. Norwegian.
Cited by
-
Do colorectal cancer patients with a postoperative stoma have sexual problems? A pooling up analysis of 2566 patients.Int J Colorectal Dis. 2023 Mar 24;38(1):79. doi: 10.1007/s00384-023-04372-2. Int J Colorectal Dis. 2023. PMID: 36961570
-
Polo-like kinase 4 is associated with advanced TNM stages and reduced survival and its inhibition improves chemosensitivity in colorectal cancer.Oncol Lett. 2022 Jun 20;24(2):269. doi: 10.3892/ol.2022.13389. eCollection 2022 Aug. Oncol Lett. 2022. PMID: 35782899 Free PMC article.
-
Incidence, risk factors, and predictive modeling of stoma site incisional hernia after enterostomy closure: a multicenter retrospective cohort study.BMC Gastroenterol. 2023 Jun 10;23(1):201. doi: 10.1186/s12876-023-02805-4. BMC Gastroenterol. 2023. PMID: 37296427 Free PMC article.
-
Sevoflurane and Propofol Co-affect the Development of Colorectal Cancer by Regulating TM2D1.Comb Chem High Throughput Screen. 2025;28(10):1669-1678. doi: 10.2174/0113862073281046240527165415. Comb Chem High Throughput Screen. 2025. PMID: 38920064
-
MiR-19a suppresses ferroptosis of colorectal cancer cells by targeting IREB2.Bioengineered. 2022 May;13(5):12021-12029. doi: 10.1080/21655979.2022.2054194. Bioengineered. 2022. PMID: 35599631 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical